| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
42,583 |
37,960 |
$3.86M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
33,011 |
28,142 |
$3.09M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
13,921 |
11,558 |
$1.42M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
17,937 |
15,033 |
$1.32M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,708 |
4,031 |
$729K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,693 |
6,498 |
$596K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,331 |
2,892 |
$425K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,729 |
5,139 |
$423K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,607 |
3,801 |
$378K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,945 |
3,709 |
$286K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,361 |
3,649 |
$218K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,824 |
1,495 |
$215K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
18,059 |
14,974 |
$215K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,742 |
1,101 |
$175K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,943 |
4,036 |
$167K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,850 |
2,534 |
$146K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,714 |
2,922 |
$137K |
| 80053 |
Comprehensive metabolic panel |
38,853 |
30,621 |
$129K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
872 |
770 |
$128K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,188 |
4,817 |
$117K |
| 71046 |
Radiologic examination, chest; 2 views |
5,271 |
4,590 |
$100K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13,384 |
10,588 |
$100K |
| 0225U |
|
3,216 |
3,122 |
$87K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
284 |
261 |
$85K |
| 81001 |
|
22,627 |
18,871 |
$82K |
| 81025 |
|
17,695 |
15,216 |
$81K |
| 87420 |
|
853 |
817 |
$80K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,288 |
1,049 |
$74K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
5,501 |
5,126 |
$65K |
| 84484 |
|
13,034 |
7,542 |
$60K |
| 71045 |
Radiologic examination, chest; single view |
14,412 |
12,203 |
$58K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
10,753 |
9,136 |
$55K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,997 |
1,881 |
$54K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,399 |
2,839 |
$51K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,991 |
1,574 |
$51K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,056 |
5,061 |
$51K |
| 81003 |
|
8,032 |
6,853 |
$50K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
677 |
631 |
$50K |
| 59025 |
Fetal non-stress test |
1,533 |
1,033 |
$48K |
| 82947 |
|
7,105 |
4,226 |
$43K |
| 96376 |
|
3,444 |
2,128 |
$41K |
| 73610 |
|
1,106 |
1,017 |
$37K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
979 |
887 |
$37K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
656 |
618 |
$36K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
611 |
533 |
$35K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
542 |
369 |
$34K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
44,043 |
33,928 |
$32K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
19,891 |
16,029 |
$30K |
| 73630 |
|
1,458 |
1,268 |
$28K |
| 84702 |
|
3,152 |
2,428 |
$26K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
607 |
562 |
$25K |
| 73130 |
|
939 |
815 |
$25K |
| G0378 |
Hospital observation service, per hour |
5,183 |
2,678 |
$24K |
| 73110 |
|
762 |
683 |
$22K |
| 87070 |
|
979 |
801 |
$20K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
474 |
432 |
$20K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,050 |
966 |
$18K |
| 73564 |
|
738 |
623 |
$17K |
| 97161 |
|
182 |
169 |
$16K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
15,289 |
11,007 |
$16K |
| 76801 |
|
1,211 |
1,016 |
$16K |
| 83880 |
|
1,956 |
1,589 |
$16K |
| 72100 |
|
951 |
847 |
$15K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
516 |
478 |
$15K |
| 92587 |
|
360 |
338 |
$14K |
| 85610 |
|
9,674 |
6,204 |
$13K |
| 86900 |
|
2,505 |
2,135 |
$13K |
| 73030 |
|
864 |
744 |
$13K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
386 |
345 |
$12K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
10,721 |
8,341 |
$11K |
| 76830 |
Ultrasound, transvaginal |
899 |
800 |
$10K |
| 80051 |
|
802 |
707 |
$10K |
| 93971 |
|
589 |
509 |
$10K |
| 80061 |
Lipid panel |
2,049 |
1,665 |
$10K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
130 |
123 |
$9K |
| 86901 |
|
2,502 |
2,135 |
$9K |
| 86850 |
|
1,133 |
949 |
$9K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,439 |
1,200 |
$9K |
| 01999 |
|
1,239 |
1,121 |
$8K |
| 74022 |
|
850 |
799 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
6,848 |
3,241 |
$8K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,422 |
1,967 |
$8K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,763 |
6,255 |
$7K |
| 85730 |
|
6,272 |
5,062 |
$7K |
| 83735 |
|
6,663 |
5,287 |
$7K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,636 |
2,070 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,460 |
2,093 |
$7K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
168 |
136 |
$7K |
| 73080 |
|
243 |
219 |
$6K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
58 |
27 |
$6K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
715 |
441 |
$6K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
235 |
207 |
$6K |
| 74018 |
|
212 |
193 |
$6K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
4,022 |
3,465 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,573 |
2,192 |
$6K |
| 87186 |
|
3,279 |
2,418 |
$5K |
| 85027 |
|
2,777 |
2,064 |
$5K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
133 |
117 |
$5K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,568 |
1,274 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,256 |
1,803 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,964 |
2,810 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
92 |
72 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
5,685 |
4,006 |
$4K |
| 71250 |
|
161 |
139 |
$4K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
14 |
12 |
$4K |
| 83605 |
|
2,558 |
1,884 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,349 |
962 |
$4K |
| 70491 |
|
14 |
13 |
$4K |
| J2704 |
Injection, propofol, 10 mg |
689 |
468 |
$4K |
| 76775 |
|
110 |
103 |
$4K |
| 83690 |
|
9,832 |
8,116 |
$4K |
| 73502 |
|
224 |
203 |
$3K |
| 73590 |
|
167 |
148 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,484 |
3,078 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,052 |
1,638 |
$3K |
| 73090 |
|
141 |
130 |
$3K |
| 84132 |
|
252 |
210 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
308 |
158 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
46 |
42 |
$3K |
| 73562 |
|
265 |
231 |
$3K |
| 82565 |
|
2,587 |
2,174 |
$3K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
63 |
59 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,091 |
1,562 |
$2K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
24 |
22 |
$2K |
| 87040 |
|
2,091 |
1,340 |
$2K |
| 84703 |
|
1,987 |
1,679 |
$2K |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
445 |
405 |
$2K |
| 87077 |
|
2,473 |
1,819 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,604 |
957 |
$2K |
| 80050 |
General health panel |
189 |
177 |
$2K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
273 |
101 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,660 |
1,380 |
$2K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
92 |
37 |
$2K |
| 12001 |
|
103 |
100 |
$1K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,917 |
1,312 |
$1K |
| 82805 |
|
45 |
38 |
$1K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
228 |
160 |
$1K |
| 74019 |
|
29 |
27 |
$1K |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
507 |
287 |
$1K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
250 |
227 |
$1K |
| 87210 |
|
2,457 |
2,104 |
$1K |
| 94761 |
|
669 |
430 |
$1K |
| 86920 |
|
24 |
12 |
$998.54 |
| J2060 |
Injection, lorazepam, 2 mg |
1,082 |
833 |
$991.04 |
| 86140 |
|
1,443 |
1,263 |
$894.90 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
372 |
313 |
$854.71 |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
315 |
130 |
$804.41 |
| 92650 |
|
33 |
30 |
$799.39 |
| 97162 |
|
26 |
25 |
$773.09 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
50 |
42 |
$716.80 |
| 73140 |
|
43 |
36 |
$600.23 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
148 |
129 |
$598.01 |
| 85379 |
|
1,066 |
937 |
$589.16 |
| 97163 |
|
16 |
13 |
$562.40 |
| 87899 |
|
20 |
14 |
$508.64 |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
14 |
12 |
$459.03 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
761 |
664 |
$436.86 |
| 36430 |
|
23 |
14 |
$402.94 |
| 80047 |
|
642 |
587 |
$390.57 |
| 76642 |
|
14 |
12 |
$382.06 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
124 |
121 |
$345.97 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,487 |
1,215 |
$336.73 |
| 85014 |
|
2,178 |
1,659 |
$330.53 |
| 84439 |
|
568 |
500 |
$314.43 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
243 |
157 |
$298.49 |
| 99152 |
|
94 |
78 |
$298.49 |
| 82550 |
|
412 |
322 |
$289.65 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
42 |
32 |
$262.65 |
| 82077 |
|
646 |
563 |
$252.82 |
| 12011 |
|
29 |
25 |
$245.73 |
| 97116 |
|
68 |
29 |
$238.91 |
| 82607 |
|
167 |
147 |
$232.68 |
| 94644 |
|
15 |
12 |
$221.70 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
473 |
404 |
$217.62 |
| 84520 |
|
1,088 |
919 |
$213.63 |
| 72070 |
|
39 |
36 |
$210.76 |
| 76870 |
|
13 |
12 |
$206.13 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
18 |
12 |
$184.39 |
| 84100 |
|
86 |
76 |
$172.88 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
75 |
45 |
$160.76 |
| 87081 |
|
1,658 |
1,584 |
$155.08 |
| 72131 |
|
31 |
26 |
$153.72 |
| 87641 |
|
55 |
52 |
$138.84 |
| 85652 |
|
732 |
601 |
$137.33 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
794 |
689 |
$102.68 |
| 72040 |
|
79 |
66 |
$101.28 |
| 85018 |
|
603 |
415 |
$77.55 |
| 90715 |
|
281 |
229 |
$77.31 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
59 |
50 |
$57.03 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
30 |
26 |
$50.88 |
| 0002A |
|
18 |
18 |
$40.00 |
| 73552 |
|
29 |
24 |
$37.87 |
| 80076 |
|
17 |
12 |
$34.60 |
| 82553 |
|
129 |
106 |
$30.97 |
| 87486 |
|
481 |
439 |
$19.41 |
| 0001A |
|
18 |
18 |
$16.94 |
| 82746 |
|
12 |
12 |
$16.13 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
42 |
37 |
$15.69 |
| 87158 |
|
124 |
113 |
$6.88 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
44 |
40 |
$6.36 |
| 87205 |
|
92 |
79 |
$2.28 |
| 82374 |
|
98 |
90 |
$1.02 |
| 84295 |
|
112 |
104 |
$1.02 |
| 82435 |
|
98 |
90 |
$1.02 |
| 84550 |
|
17 |
15 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
57 |
26 |
$0.00 |
| 80143 |
|
73 |
67 |
$0.00 |
| 80179 |
|
110 |
100 |
$0.00 |
| 10060 |
|
12 |
12 |
$0.00 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
16 |
12 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
57 |
39 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
48 |
40 |
$0.00 |
| 82010 |
|
40 |
38 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
14 |
12 |
$0.00 |
| 87045 |
|
14 |
14 |
$0.00 |
| 84145 |
|
112 |
105 |
$0.00 |
| 29125 |
|
12 |
12 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
16 |
15 |
$0.00 |
| 83615 |
|
27 |
25 |
$0.00 |
| C1769 |
Guide wire |
131 |
104 |
$0.00 |
| 87581 |
|
457 |
420 |
$0.00 |
| 86592 |
|
15 |
14 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
40 |
25 |
$0.00 |
| 88304 |
|
20 |
13 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
42 |
30 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
15 |
12 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
34 |
12 |
$0.00 |